Your browser doesn't support javascript.
Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2".
Du, Yin-Xiao; Chen, Xiao-Ping.
  • Du YX; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Chen XP; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan, China.
Clin Pharmacol Ther ; 108(2): 190, 2020 08.
Article in English | MEDLINE | ID: covidwho-1384147

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / SARS Virus / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: Clin Pharmacol Ther Year: 2020 Document Type: Article Affiliation country: CPT.1878

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / SARS Virus / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: Clin Pharmacol Ther Year: 2020 Document Type: Article Affiliation country: CPT.1878